Optimal use of intravenous tranexamic acid for hemorrhage prevention in pregnant women

BACKGROUND: Every 2 minutes there is a pregnancy related death worldwide, with one third due to severe postpartum hemorrhage (PPH). While international trials demonstrated efficacy of 1,000 mg TXA in treating PPH, to our knowledge there are no dose finding studies of TXA in pregnant women for PPH pr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Obstet Gynecol
Egile Nagusiak: AHMADZIA, Homa K., LUBAN, Naomi L.C., LI, Shuhui, GUO, Dong, MISZTA, Adam, GOBBURU, Jogarao V.S., BERGER, Jeffrey S., JAMES, Andra H., WOLBERG, Alisa S., VAN DEN ANKER, John
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8149481/
https://ncbi.nlm.nih.gov/pubmed/33248975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2020.11.035
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak